Affymax, Inc. (AFFY)

OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Jan 21, 2026, 9:30 AM EST
14.29%
Market Cap59.59K
Revenue (ttm)42.00K -99.9%
Net Income3.07M
EPS0.08
Shares Out74.49M
PE Ratio0.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume20,444
Open0.0008
Previous Close0.0008
Day's Range0.0008 - 0.0008
52-Week Range0.0001 - 0.0030
Beta8.05
RSI47.53
Earnings Daten/a

About Affymax

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol AFFY
Full Company Profile

Financial Performance

In 2013, Affymax's revenue was $1.37 million, a decrease of -98.55% compared to the previous year's $94.37 million. Losses were -$14.42 million, -84.56% less than in 2012.

Financial Statements